- Patent Title: Treatment of diseases mediated by thyroid and parathyroid hormones
-
Application No.: US16348924Application Date: 2017-11-10
-
Publication No.: US11571574B2Publication Date: 2023-02-07
- Inventor: Hans Jakob Kristoffer Famm , Harumi Hotta , Arun Sridhar
- Applicant: Galvani Bioelectronics Limited , Tokyo Metropolitan Institute of Gerontology
- Applicant Address: GB Brentford Middlesex; JP Tokyo
- Assignee: Galvani Bioelectronics Limited,Tokyo Metropolitan Institute of Gerontology
- Current Assignee: Galvani Bioelectronics Limited,Tokyo Metropolitan Institute of Gerontology
- Current Assignee Address: GB Brentford Middlesex; JP Tokyo
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: GB1619049 20161111
- International Application: PCT/EP2017/078954 WO 20171110
- International Announcement: WO2018/087330 WO 20180517
- Main IPC: A61N1/36
- IPC: A61N1/36 ; A61N1/05 ; A61N5/06 ; A61N7/02
Abstract:
Modulation of neural activity in the superior laryngeal nerve (SLN) or cervical sympathetic trunk (CST) is effective in treating diseases and conditions mediated by thyroid and parathyroid hormones, in particular diseases associated with calcitonin secretion (e.g. osteoporosis) or diseases associated with thyroxine secretion (e.g. hypothyroid syndrome).
Public/Granted literature
- US20190262613A1 TREATMENT OF DISEASES MEDIATED BY THYROID AND PARATHYROID HORMONES Public/Granted day:2019-08-29
Information query
